Showing results (521-530 of 577) with videos related to
Sort By:
Pageof 58
Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.Science (New York, N.Y.)|July 15, 2020
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patientsJérôme Hadjadj, Nader Yatim, Laura Barnabei, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2017
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled TrialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.Journal of the American Society of Nephrology : JASN|May 7, 2025
Histologic Features Associated with Kidney Survival in Scleroderma Renal CrisisYannick Binois, David Buob, Marie-Sophie Meuleman, et al.BJOG : an International Journal of Obstetrics and Gynaecology|December 20, 2024
Safety of Fertility Treatments in Women With Systemic Lupus Erythematosus: Data From a Prospective Population-Based StudyAmandine Dernoncourt, Gaëlle Guettrot-Imbert, Loïc Sentilhes, et al.The Lancet. Rheumatology|April 26, 2021
Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trialBrett D Thombs, Linda Kwakkenbos, Brooke Levis, et al.Arthritis and Rheumatism|December 1, 2007
Vasculitides associated with malignancies: analysis of sixty patientsOlivier Fain, Mohamed Hamidou, Patrice Cacoub, et al.Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.Orphanet Journal of Rare Diseases|July 26, 2021
French recommendations for the management of systemic sclerosisEric Hachulla, Christian Agard, Yannick Allanore, et al.Pageof 58